Angiolink Corporation
company
About
Angiolink privately held medical device company focused on developing innovative wound closure solutions for vascular procedures.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $10.60M
- Industries
- Biotechnology,Health Care,Innovation Management,Medical,Medical Device
- Founded date
- Jan 1, 1999
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Angiolink Corporation offers EVS vascular closure system, an arterial stapling device for use in closing holes and punctures made in arteries in connection with the catheter-based surgical procedures, such as angioplasty and angiograms.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$24.20M
Angiolink Corporation has raised a total of
$24.20M
in funding over 2 rounds. Their latest funding was raised on
Sep 10, 2003 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 10, 2003 | Series B | $13.60M | 1 | — | — | Detail |
| Sep 17, 2002 | Series A | $10.60M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Angiolink Corporation is funded by 1 investors.
Boston Financial & Equity Corporation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Boston Financial & Equity Corporation
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
